Results 1 to 10 of about 2,804,406 (287)

The “Lightbulb” Sign [PDF]

open access: yesJACC: Case Reports, 2023
We report a case of fulminant COVID-19–related myocarditis requiring venoarterial extracorporeal membrane oxygenation where the use of an ultrasound-enhancing agent demonstrated a previously undescribed echocardiographic finding, the “lightbulb” sign ...
Ayana Nanthakumar   +7 more
doaj   +4 more sources

Validation of administrative claims to identify ultrasound enhancing agent use [PDF]

open access: yesEcho Research and Practice
Background Ultrasound enhancing agents (UEAs) are an invaluable adjunct to stress and transthoracic echocardiography (STE) to improve left ventricular visualization. Despite multiple single center studies evaluating UEA use, investigation into the rates,
Jordan B. Strom   +6 more
doaj   +4 more sources

Identification of Need for Ultrasound Enhancing Agent Study (the IN-USE Study) [PDF]

open access: yesJournal of the American Society of Echocardiography, 2020
Ultrasound enhancing agents (UEAs) are routinely used to improve transthoracic echocardiographic (TTE) image quality, yet anticipation of UEA need is a barrier to their use.Structured report data from 171,509 consecutive TTE studies in 97,515 patients who underwent TTE imaging from January 26, 2000, to September 20, 2018, were analyzed.
Sherif F Nagueh, Jordan B Strom
exaly   +5 more sources

Selective Enhancement of Swine Myocardium with a Novel Ultrasound Enhancing Agent During Transthoracic Echocardiography [PDF]

open access: yesJournal of Cardiovascular Translational Research, 2022
Ultrasound enhancing agents are approved to delineate the endocardial border and opacify the left ventricle cavity (LVC). We present a nested phase change agent (NPCA) designed to enable selective myocardial enhancement without enhancing the LVC by employing a dual-activation mechanism dependent on sufficient ultrasound intensity and the ...
Michael Flynn   +2 more
exaly   +4 more sources

External Validation of the Identification of Need for Ultrasound Enhancing Agent Study (the IN-USE Study) [PDF]

open access: yesJournal of the American Society of Echocardiography, 2022
Jordan B Strom   +2 more
exaly   +2 more sources

CEUS cardiac exam protocols International Contrast Ultrasound Society (ICUS) recommendations

open access: yesEcho Research and Practice, 2022
The present CEUS Cardiac Exam Protocols represent the first effort to promulgate a standard set of protocols for optimal administration of ultrasound enhancing agents (UEAs) in echocardiography, based on more than two decades of experience in the use of ...
Thomas R. Porter   +10 more
doaj   +1 more source

An imaging artifact unmasked by contrast‐enhanced transesophageal echocardiography

open access: yesClinical Case Reports, 2023
Key Clinical Message Performing transesophageal imaging of the left atrial appendage is key before cardioversion for atrial fibrillation. Ultrasound artifacts may induce misinterpretation and decrease in confidence for thrombus exclusion.
Colin Hannesse   +2 more
doaj   +1 more source

Improved efficiency and diagnostic utility of inpatient transthoracic echocardiography following implementation of a sonographer-initiated perflutren-based contrast administration protocol

open access: yesCardiovascular Ultrasound, 2020
Background Up to 20% of resting echocardiograms obtained are suboptimal leading to further downstream testing and delays in diagnosis. Contrast enhanced echocardiography is well established and endorsed for use by the American Society of Echocardiography
Ryan Prentice   +4 more
doaj   +1 more source

Exosomes and ultrasound: The future of theranostic applications

open access: yesMaterials Today Bio, 2023
Biomaterials and pertaining formulations have been very successful in various diagnostic and therapeutic applications because of its ability to overcome pharmacological limitations.
Badrinathan Sridharan, Hae Gyun Lim
doaj   +1 more source

Home - About - Disclaimer - Privacy